Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 36 entries
View as:

To Investigate the Multiple Dose Safety, Tolerability and Pharmacokinetics of WCK 4282 (FEP-TAZ)

Phase: N/A Priority: Normal
NCT ID: NCT03622008 Org: User:
Start: 03/23/18 End: 05/30/18 Due: 05/30/19

The Safety, Tolerability And Pharmacokinetics Of Single Ascending Doses And The Effect Of Food On Oral WCK 4873 In Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03926962 Org: User:
Start: 03/14/13 End: 07/13/13 Due: 07/13/14

Comparative Glucose Clamp Study of Wockhardt's Insulin Human Regular for Injection and Actrapid, in Healthy Subjects.

Phase: N/A Priority: Normal
NCT ID: NCT00719108 Org: User:
Start: 07/31/08 End: 09/30/08 Due: 09/30/09

Study to Evaluate the Effect Of WCK 2349 on the QT/QTc Interval in Health Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02217930 Org: User:
Start: 08/31/14 End: 07/31/15 Due: 07/31/16

MED Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous WCK 5222 (Zidebactam and Cefepime) in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02707107 Org: User:
Start: 03/31/16 End: 04/30/16 Due: 04/30/17

A Single-center, Open-label, Study Evaluating Safety and Pharmacokinetics of Single Doses of Zidebactam-Cefepime and Metronidazole Alone or in Combination.

Phase: N/A Priority: Normal
NCT ID: NCT06806995 Org: User:
Start: 01/27/25 End: 07/31/25 Due: 07/31/26

Evaluate the Effect of WCK 5222 on the QT/QTc Interval in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03554304 Org: User:
Start: 02/09/17 End: 10/06/17 Due: 10/06/18

Immunogenicity Study of Wockhardt's Insulin Lispro/Lispro Mix Basal Bolus Regimen in Type 1 Diabetics

Phase: N/A Priority: Normal
NCT ID: NCT01398670 Org: User:
Start: 02/29/12 End: 05/31/13 Due: 05/31/14

Comparative Bioequivalence Study of Wockhardt's Insulin Analogue Lispro (Listro™) With Humalog® in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01399255 Org: User:
Start: 11/30/11 End: 06/30/12 Due: 06/30/13

Phase I, Open Label,Crossover Food-Effect and Absolute Bioavailability Study of WCK2349 and WCK771 in Healthy Adult Human Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01875939 Org: User:
Start: 06/30/13 End: 06/30/13 Due: 06/30/14

Comparative Glucose Clamp Study of Wockhardt's Recombinant Insulin Analog Glargine(Glaritus) With Lantus in T1DM

Phase: N/A Priority: Normal
NCT ID: NCT01357603 Org: User:
Start: 06/30/11 End: 08/31/12 Due: 08/31/13

Pharmacokinetics of WCK 2349 In Patients With Hepatic Impairment

Phase: N/A Priority: Normal
NCT ID: NCT02244827 Org: User:
Start: 09/30/14 End: 06/30/15 Due: 06/30/16

Comparative Glucose Clamp Study of Wockhardt's Insulin Human Regular for Injection and Novolin R, in Healthy Subjects.

Phase: N/A Priority: Normal
NCT ID: NCT00596063 Org: User:
Start: 01/31/08 End: 02/29/08 Due: 02/28/09

Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of Oral WCK 2349

Phase: N/A Priority: Normal
NCT ID: NCT04874324 Org: User:
Start: 03/17/11 End: 06/25/11 Due: 06/25/12

Study of Cefepime-tazobactam (FEP-TAZ) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)

Phase: N/A Priority: Normal
NCT ID: NCT03630081 Org: User:
Start: 01/31/24 End: 02/28/26 Due: 02/28/27

Immunosafety Study of Recombinant Human Insulins in Type 1 Diabetics

Phase: N/A Priority: Normal
NCT ID: NCT01308437 Org: User:
Start: 03/31/11 End: 04/30/13 Due: 04/30/14

Study to Determine and Compare Plasma and Intrapulmonary Concentrations of WCK 4873 in Healthy Adult Human Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02453529 Org: User:
Start: 04/30/15 End: 07/31/15 Due: 07/31/16

Phase II Study of Oral Nafithromycin in CABP

Phase: N/A Priority: Normal
NCT ID: NCT02903836 Org: User:
Start: 11/18/16 End: 07/08/17 Due: 07/08/18

A Single-dose Study to Investigate the Pharmacokinetics of Intravenous FEP-TAZ in Patients With Renal Impairment

Phase: N/A Priority: Normal
NCT ID: NCT02709382 Org: User:
Start: 03/31/16 End: 08/31/16 Due: 08/31/17

Plasma and Intrapulmonary Concentrations Study of WCK 5222

Phase: N/A Priority: Normal
NCT ID: NCT03630094 Org: User:
Start: 03/31/17 End: 07/30/17 Due: 07/30/18

Immunogenicity Safety Study of Wockhardt's Recombinant Insulin Analogue in Type 1 Diabetic Patients

Phase: N/A Priority: Normal
NCT ID: NCT01352663 Org: User:
Start: - End: - Due: -

Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of Intravenous WCK 771

Phase: N/A Priority: Normal
NCT ID: NCT05640531 Org: User:
Start: 12/01/11 End: 06/27/12 Due: 06/27/13

A Phase 1 Pharmacokinetic Study of Single-Ascending Doses of Intravenous Nafithromycin in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02770404 Org: User:
Start: 04/25/16 End: 12/25/16 Due: 12/25/17

Comparative Glucose Clamp Study of Wockhardt's Human Isophane Insulin With Novolin N,in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00772265 Org: User:
Start: 09/30/10 End: 04/30/11 Due: 04/30/12

Comparative Glucose Clamp Study of Wockhardt's Insulin Human Regular for Injection and Actrapid, in Type 1 Diabetics

Phase: N/A Priority: Normal
NCT ID: NCT00752180 Org: User:
Start: 08/31/08 End: 04/30/09 Due: 04/30/10